| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.097 | 0.06 |